Spray Skin Treats for Pediatric Burns

February 6, 2024 updated by: Hu Zhicheng, First Affiliated Hospital, Sun Yat-Sen University

Spray Skin Treats in the Treatment of Pediatric Burns

The treatment of burns in children remains a global challenge. At present, the clinical treatment plan is still waiting for further improvement. This study intends to retrospectively analyze the experience of treating children burn in recent years and promote sharing and application.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The treatment of burns in children remains a global challenge. Children's burn wounds have many characteristics that are different from those of adults, such as easy deepening of the wound, uncooperation in dressing change, poor resistance and so on. At present, there are new dressing applications a nd surgery in clinical treatment, etc., but how to treat children to achieve better therapeutic effects still needs to be explored. This study intends to retrospectively analyze the experience of treating children burn in recent years and promote sharing and application.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510080
        • Recruiting
        • Department of Burn Surgery, The First Affiliated Hospital of Sun Yat-sen University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Children with burns from various reasons

Description

Inclusion Criteria:

  • burn for any reasons
  • Children

Exclusion Criteria:

  • Combined with mental illness
  • Congenital immune disease
  • Severe cardiopulmonary failure,etc

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control group
Autologous skin graft was used to treat burn wound
skin graft
Experiment gourp
Autologous skin cell suspension combined with autologous skin graft was used to treat burn wound
autologous skin cell suspension combined with skin graft

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
take rate
Time Frame: postoperative day 4 weeks
take rate of skin graft
postoperative day 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
complication rate
Time Frame: through study completion, an average of 6 months
after skin grafting, skin infection, necrosis, subcutaneous hematoma, etc
through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jiayuan Zhu, First Affiliated Hospital, Sun Yat-Sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2012

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

December 13, 2023

First Submitted That Met QC Criteria

December 23, 2023

First Posted (Actual)

December 26, 2023

Study Record Updates

Last Update Posted (Actual)

February 8, 2024

Last Update Submitted That Met QC Criteria

February 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SYSU-FAH-20231208

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Burn

Clinical Trials on spray skin

3
Subscribe